Home New Customer? Create Account
Member Login:

EpitoGen COVID-19 ELISA Tests

EpitoGen COVID-19 ELISA Tests

The new EpitoGen Technology from Vertebrate Antibodies Ltd provides a novel platform for improved antibody tests. Using this platform, several unique, highly sensitive COVID-19 ELISA tests have been developed. 

 

EpitoGen COVID-19 ELISA Tests are the only epitope-based ELISA tests and the only tests to utilize 5 viral COVID-19 antigens and include prevalent mutations

 

These assays detect a population level spectrum of COVID-19 IgG antibodies specific to the spike, nucleocapsid and other COVID-19 viral proteins. The epitopes selected are IgM and IgA rich, making the assays suitable for the detection of IgA and IgM antibody responses. The high sensitivity of the assays makes them ideal for the study of immune response to both natural infection and vaccination for COVID-19. 

 

Several tests are available, each with specific functions:

  • EpitoGen Universal - Detection of antibody response to 15 epitopes from five COVID-19 viral proteins including corresponding mutants (45 prevalent mutations)

  • EpitoGen Differential – Differentiation of antibody response to vaccination-induced and infection-induced protection

  • EpitoGen Immunity – Evaluation of antibody response following vaccination or natural infection and antibody response against the original and mutant COVID-19

  • EpitoGen Spike Mutant - Detection of antibodies specific to variant forms of COVID-19 spike protein

 

These tests provide reliable data that is critical to ongoing designs of diagnostics and vaccines, particularly with respect to emerging variant forms of COVID-19.